[1]
Bonanad, S., Álvarez, M.T., Núñez, R., Poveda, J.L., Gil, B., Ruíz-Beato, E., Durán, A., Ivanova, Y., Pérez-Román, I. and González-Domínguez, A. 2021. Costs of the management of hemophilia A with inhibitors in Spain. Global & Regional Health Technology Assessment. 8, (Apr. 2021), 35–42. DOI:https://doi.org/10.33393/grhta.2021.2234.